Invenomic Capital Management LP [Rocket]

Date Filed	Type	Description
08/14/2023	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/15/2023	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2023	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/10/2023	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2023	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2023	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/14/2022	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/15/2022	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/16/2022	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
03/10/2022	SC 13G/A	Invenomic Capital Management LP reports a 5% stake in Immersion Corporation.
02/11/2022	SC 13G	Invenomic Capital Management LP reports a 5.1% stake in Immersion Corporation.
02/11/2022	SC 13G	Invenomic Capital Management LP reports a 6% stake in Lexaria Bioscience Corp.
02/11/2022	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/15/2021	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/16/2021	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/13/2021	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/17/2021	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/13/2020	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/13/2020	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/13/2020	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2020	13F-HR	Form 13F-HR - Quarterly report filed by institutional managers, Holdings: